Monticello T M, Sargent C A, McGill J R, Barton D S, Grover G J
Department of Experimental Pathology, The Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ 08543-4000, USA.
Cardiovasc Res. 1996 Jan;31(1):93-101.
Aims of this study were: (1) Evaluate by morphology and specific physiological and biochemical parameters, the protective effects of the cardioselective ATP-sensitive potassium channel opener BMS-180448 on ischemic/reperfused isolated rat heart, and (2) Determine the earliest time point ischemia-induced myocardial injury is observed by light microscopy.
Hearts from Sprague-Dawley rats were perfused on a Langendorff apparatus. After equilibration, hearts were treated with BMS-180448 (10 micro M) or vehicle (0.04% DMSO) for 10 min before the onset of ischemia. Four hearts/group were collected following 10, 18, or 25 min of ischemia. A nonischemic control group was also evaluated. Following 25 min of ischemia, another set of hearts was reperfused with oxygenated Krebs-Hensleit solution and allowed to recover for 30 min. Light and electron microscopic changes of the myocardium were semi-quantitatively evaluated together with physiological (i.e., heart rate, left ventricular diastolic pressure, time to contracture formation) and biochemical (i.e., lactate dehydrogenase, LDH, release) endpoints.
Cardioprotective effects of BMS-180448 following ischemia/reperfusion consisted of a reduced rate of contracture formation, reduced LDH release, and enhanced recovery of contractile function during reperfusion (P < 0.05). Light microscopic evidence of myocardial damage was detected following 18 min of ischemia. Morphological changes in ischemic/reperfused hearts included interstitial edema, myofiber degeneration, and hypercontraction band formation. Ultrastructurally, swollen myofibrils, swollen mitochondria with disrupted cristae and electron-dense deposits, myofibrillar lysis, and contraction bands, were observed. Light and electron microscopic severity scores were significantly less (P < 0.05) in BMS-180448-treated hearts at the 25 min ischemic time point and in reperfused hearts, as compared to similarly-treated vehicle hearts.
BMS-180448 ameliorates morphological evidence of ischemia/reperfusion myocardial damage in the isolated rat heart model, in agreement with physiological and biochemical parameters.
本研究的目的为:(1)通过形态学以及特定的生理和生化参数,评估心脏选择性ATP敏感性钾通道开放剂BMS-180448对缺血/再灌注离体大鼠心脏的保护作用;(2)确定通过光学显微镜观察到缺血诱导心肌损伤的最早时间点。
将来自Sprague-Dawley大鼠的心脏在Langendorff装置上进行灌注。平衡后,在缺血开始前,心脏用BMS-180448(10微摩尔)或溶媒(0.04%二甲基亚砜)处理10分钟。缺血10、18或25分钟后,每组收集4个心脏。还评估了一个非缺血对照组。缺血25分钟后,另一组心脏用含氧的Krebs-Hensleit溶液进行再灌注,并使其恢复30分钟。对心肌的光镜和电镜变化以及生理(即心率、左心室舒张压、出现挛缩的时间)和生化(即乳酸脱氢酶、LDH、释放)终点进行半定量评估。
缺血/再灌注后BMS-180448的心脏保护作用包括挛缩形成率降低、LDH释放减少以及再灌注期间收缩功能恢复增强(P<0.05)。缺血18分钟后检测到心肌损伤的光镜证据。缺血/再灌注心脏的形态学变化包括间质水肿、肌纤维变性和超收缩带形成。在超微结构上,观察到肌原纤维肿胀、线粒体肿胀伴嵴断裂和电子致密沉积物、肌原纤维溶解以及收缩带。与同样处理的溶媒心脏相比,在25分钟缺血时间点,BMS-180448处理的心脏以及再灌注心脏的光镜和电镜严重程度评分显著更低(P<0.05)。
BMS-180448改善了离体大鼠心脏模型中缺血/再灌注心肌损伤的形态学证据,这与生理和生化参数一致。